October 3, 2024
Medicare will speed nationwide payment decisions for as many as five promising new medical devices a year, a move that could get some products to patients […]
October 3, 2024
At the end of 2020, Giulia Marchetti was puzzled that many of the patients hospitalized during the first wave of the COVID-19 pandemic were returning to […]
October 3, 2024
BARCELONA, Spain — Trastuzumab deruxtecan (TDXd) shows promise as a treatment for HER2-low and HER2-ultralow hormone receptor (HR)–positive metastatic breast cancer, according to data from the […]
October 3, 2024
AMSTERDAM — Following the report of results from a randomized trial in which a topically applied Janus kinase (JAK) inhibitor was highly active in patients with […]
October 3, 2024
BARCELONA, Spain — Early findings from a real-world study of the dual-action antibody faricimab have shown sustained improvement in visual acuity and key biomarkers of retinal […]
October 3, 2024
Newly issued guidelines for cancer screening in patients with dermatomyositis had 100% sensitivity in a single institution’s cohort, though most of the cancers found would have […]
October 3, 2024
A new approach to using stem cell–derived pancreatic islets has allowed a patient with type 1 diabetes (T1D) to come off insulin for 1 year. The […]
October 3, 2024
More women are matriculating to higher-paid physician specialty fields, especially surgery, but they still have a way to go before reaching parity with their male counterparts, […]
October 3, 2024
What is FDA posting? The following reports list potential signals of serious risks/new safety information that were identified using the FAERS database during the indicated quarter. […]